1. Home
  2. SER vs MGLD Comparison

SER vs MGLD Comparison

Compare SER & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.12

Market Cap

56.4M

Sector

Health Care

ML Signal

HOLD

Logo The Marygold Companies Inc.

MGLD

The Marygold Companies Inc.

SELL

Current Price

$1.97

Market Cap

84.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
SER
MGLD
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.4M
84.8M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
SER
MGLD
Price
$1.12
$1.97
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $9.50
N/A
AVG Volume (30 Days)
★ 67.0K
20.1K
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.57
EPS
N/A
★ 0.04
Revenue
N/A
★ $34,876,734.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$49.25
Revenue Growth
★ N/A
N/A
52 Week Low
$1.14
$0.84
52 Week High
$4.26
$2.12

Technical Indicators

Market Signals
Indicator
SER
MGLD
Relative Strength Index (RSI) 27.64 70.10
Support Level N/A $0.92
Resistance Level $1.96 $2.12
Average True Range (ATR) 0.19 0.01
MACD -0.03 -0.02
Stochastic Oscillator 5.13 50.00

Price Performance

Historical Comparison
SER
MGLD

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include Fund Management through USCF Investments, Security Systems, Financial Services, Beauty Products, and Corporate Headquarters. The majority of revenue comes from fund management. The company operates in the United States, the United Kingdom, and Canada. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

Share on Social Networks: